| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $371.3M | -1.3% |
| Cost of Revenue | $205.6M | +0.1% |
| R&D Expense | $33.7M | -8.9% |
| SG&A Expense | $51.2M | -16.4% |
| Operating Income | -$73.6M | +1.7% |
| Pre-tax Income | -$77.8M | -20.0% |
| Income Tax | $1.5M | -11.1% |
| Net Income | -$79.4M | -19.2% |
| EPS (Basic) | -$19.88 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.8M | +13.5% |
| Accounts Receivable | $63.8M | -6.8% |
| Current Assets | $98.0M | -6.5% |
| Total Assets | $491.3M | -15.4% |
| Current Liabilities | $182.6M | +10.6% |
| Total Liabilities | $247.3M | -0.5% |
| Stockholders' Equity | $56.1M | -61.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.9M | -17.2% |
| Capital Expenditures | $1.6M | +39.0% |
| Investing Cash Flow | -$23.8M | -33.5% |
| Financing Cash Flow | -$3.4M | +81.3% |
| Free Cash Flow | $27.3M | -19.1% |
| -2133.7% |
| EPS (Diluted) | -$19.88 | -2133.7% |